NCT06485505View on ClinicalTrials.gov

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2024

Conditions
Onychomycosis
Interventions
DRUG

ISOtretinoin 10 MG

Low dose isotretinoin as an adjuvant for itraconazole in treating onychomycosis

DEVICE

excimer light

excimer light as an adjuvant for itraconazole in treating onychomycosis

DRUG

Itraconazole 200 mg

Itraconazole alone

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT06485505 - Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis | Biotech Hunter | Biotech Hunter